How many Protagonist Therapeutics shares are in issue?
Protagonist Therapeutics has 59,598,018 shares in issue.
What is the market cap of Protagonist Therapeutics?
The market capitalisation of Protagonist Therapeutics is USD 2.61 B.
What is the 1 year trading range for Protagonist Therapeutics share price?
Protagonist Therapeutics has traded in the range of US$ 17.89 to US$ 48.89 during the past year.
What is the PE ratio of Protagonist Therapeutics?
The price to earnings ratio of Protagonist Therapeutics is -33.06.
What is the cash to sales ratio of Protagonist Therapeutics?
The cash to sales ratio of Protagonist Therapeutics is 43.51.
What is the reporting currency for Protagonist Therapeutics?
Protagonist Therapeutics reports financial results in USD.
What is the latest annual turnover for Protagonist Therapeutics?
The latest annual turnover of Protagonist Therapeutics is USD 60M.
What is the latest annual profit for Protagonist Therapeutics?
The latest annual profit of Protagonist Therapeutics is USD -78.96M.
What is the registered address of Protagonist Therapeutics?
The registered address for Protagonist Therapeutics is 251 LITTLE FALLS DRIVE, WILMINGTON, DELAWARE, 19808.
What is the Protagonist Therapeutics website address?
The website address for Protagonist Therapeutics is www.protagonist-inc.com.
Which industry sector does Protagonist Therapeutics operate in?
Protagonist Therapeutics operates in the PHARMACEUTICAL PREPARATIONS sector.
Register to chat with like-minded investors on our interactive forums.
Hot Features
Premium
